01.01.2003 | Short Communication
Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemia
Erschienen in: Cancer Chemotherapy and Pharmacology | Ausgabe 1/2003
Einloggen, um Zugang zu erhalten